Tumorigenesis and Neoplastic Progression Decreased TIP 30 Expression Promotes Tumor Metastasis in Lung Cancer
Xin Tong,Kai Li,Zhigang Luo,Bin Lu,Xing Liu,Tao Wang,Mingshu Pang,Beibei Liang,Min Tan,Mengchao Wu,Jian Zhao,Yajun Guo
2010-01-01
Abstract:The HIV Tat-interacting protein (TIP30), also called CC3 or HTIP2, is encoded by Tip30 , a putative tumorsuppressor gene located on human chromosome 11p15.1. In this study, we investigated the role of TIP30 in the progression and metastasis of lung cancer. TIP30 expression was analyzed in 206 paired lung cancers and adjacent non-tumor tissues, as well as in 70 matched lymph node metastases using a high-density tissue microarray. Results were compared with the clinicopathologic features of the patients from whom the tissues were taken. Low TIP30 expression levels were found in all 9 cases of small cell lung cancer and in 36.5% (72/197) of non-small cell lung cancer, which were correlated with lymph node metastasis in non-small cell lung cancer and with poor differentiation and advanced stage of tumor cells in squamous cell carcinoma. The immunostaining scores were significantly lower in the metastatic lesions than in the primary lesions. Down-regulation of TIP30 by a short hairpin RNA enhanced cell survival, migration, and invasion through Matrigel in vitro , and promoted lung metastasis and vascularization in nude mice. Further studies revealed that the downregulation of TIP30 enhanced the expression of osteopontin, as well as matrix metalloproteinase-2 and vascular endothelial growth factor. Our results suggest that the down-regulation of TIP30 promotes metastatic progression of lung cancer, hence it could serve as a potential target for the development of lung cancer therapies. (Am J Pathol 2009, 174:1931–1939; DOI: 10.2353/ajpath.2009.080846) Lung cancer is one of the leading causes of death worldwide. In China, about 300,000 new cases of lung cancer, causing more than 250,000 deaths, occur annually. The prognosis for lung cancer remains poor despite of the improvements made over the years to its management and treatment. The overall survival of patients with lung cancer remains at a dismal 15% because of metastasis and the development of resistance to chemotherapy. Therefore, it is important to better understand the molecular mechanisms of lung cancer progression and find more effective targets for improving the outcomes for patients with lung cancer. The 30-kDa HIV Tat-interacting protein (TIP30), also called CC3 or HTIP2, is a tumor suppressor with proapoptotic and anti-metastasis properties. The Tip30 gene is located on human chromosome 11p15.1. It was originally identified by a differential display analysis of mRNA from the highly metastatic human variant small cell lung cancer (SCLC) versus less metastatic classic SCLC cell line. The expression of TIP30 is mainly located in cytoplasm. Decreased TIP30 expression has been detected in some tumor cells, such as melanoma, breast cancer, neuroblastoma, glioblastoma, colon cancer, and hepatocellular carcinoma. About 24% of various types of cancer cells had Tip30 missense mutation in exon 3 by comparing the Tip30 cDNA sequences in National Center for Biotechnology Information databases. G134V mutation derived from liver cancer significantly shortened the half-life of TIP30 protein. Besides gene mutations, TIP30 expression was recently found